Rectify pharma
WebMar 6, 2024 · Rectify Pharmaceuticals is a biotechnology company based in Cambridge, MA. Rectify is developing Positive Functional Modulators (PFMs), disease-modifying precision therapeutics that restore ABC transporter function for … WebOct 14, 2024 · Contact Information Website www.rectifypharma.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 400 Technology Square Second floor, Suite 201 Cambridge, MA 02139 United States Want detailed data on 3M+ …
Rectify pharma
Did you know?
WebNov 15, 2024 · Rectify Pharma. D'Amore-McKim School of Business at Northeastern University. Report this profile Report Report. Back Submit. Contact Anna for services Change Management, Team Building, Program ... WebOct 14, 2024 · CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company developing Positive Functional Modulators (PFMs), …
WebDec 12, 2024 · CAMBRIDGE, Mass. – December 12, 2024 – Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company developing small molecule disease-modifying therapeutics that restore and enhance ABC transporter function, announced the publication of an article highlighting the therapeutic potential of the ABC transporter class in Trends … WebRectify is a privately held Series A company located in Cambridge, MA. We are looking for a talented and motivated scientist with significant assay development experience supporting small molecular drug discovery to join our passionate and collaborative team to help drive our internal programs.
WebRob is EVP of drug discovery and preclinical development at Rectify Pharmaceuticals; previously he was head of molecular discovery at Disarm Therapeutics which was … WebRectify Pharma Jun 2024 - Present4 years 10 months Cambridge, MA Principal Investigator - Department of Biology Massachusetts Institute of Technology Jun 2024 - Oct 20242 years …
WebFeb 14, 2024 · CAMBRIDGE, Mass., February 14, 2024 -- ( BUSINESS WIRE )-- Rectify Pharmaceuticals, Inc., ("Rectify") a biotechnology company developing small molecule …
WebOct 17, 2024 · Rectify Pharmaceuticals Location 300 Technology Sq Fl 8, Cambridge, Massachusetts, 02139, United States Description Read More Industry Business Services General Business Services Discover more about Rectify Pharmaceuticals Tracey Dawson Work Experience and Education Work Experience Head Corporate Strategy Chief … it yrs license verifiableWebApr 10, 2024 · On Friday, April 7, a federal judge with no scientific training fundamentally undermined the bipartisan authority granted by Congress to the Food and Drug Administration to approve and regulate safe, effective medicines for every American. District Judge Matthew Kacsmaryk issued a decision that overturns the FDA’s 23-year-old … netherlands job search websitesWebRectify Pharma Jan 2024 - Present1 year 4 months Cambridge, MA Rectify is developing disease-modifying precision therapies that restore ABC … i type with purposeWebOct 14, 2024 · –Disease-modifying therapeutics for patients with genetic diseases caused by mutations in ABC transporters – CAMBRIDGE, Mass.--(BUSINESS WIRE)--Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company developing Positive Functional Modulators (PFMs), disease-modifying therapeutics that restore ABC transporter function, … ityrgWebLab Manager/Research Associate. Rectify Pharmaceuticals is focused on delivering life-changing therapies to people with serious ABC transporter mediated diseases. We have built a breakthrough ABC transporter product platform that is enabling efficient and rapid discovery of first-in-class small molecule therapies that restore and enhance ABC ... ity rootWebFeb 14, 2024 · CAMBRIDGE, Mass., February 14, 2024 -- ( BUSINESS WIRE )-- Rectify Pharmaceuticals, Inc., ("Rectify") a biotechnology company developing small molecule disease-modifying therapeutics that... netherlands jobs chineseWebOct 14, 2024 · Rectify Pharmaceuticals launched with $100 million in a series A financing to develop disease-modifying therapeutics that restore ABC transporter function. Atlas Venture, Omega Funds, Forbion, and Longwood Fund co-led the financing, which will be used to fund the company through its first human proof-of-concept studies. netherlands job opportunities for foreigners